Wealthspire Advisors (New York)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $744K | Buy |
6,926
+719
| +12% | +$77.2K | ﹤0.01% | 443 |
|
|
2025
Q1 | $626K | Buy |
6,207
+198
| +3% | +$20K | ﹤0.01% | 467 |
|
|
2024
Q4 | $537K | Buy |
6,009
+1,773
| +42% | +$158K | 0.01% | 496 |
|
|
2024
Q3 | $355K | Buy |
4,236
+410
| +11% | +$34.4K | ﹤0.01% | 581 |
|
|
2024
Q2 | $295K | Buy |
3,826
+80
| +2% | +$6.16K | ﹤0.01% | 546 |
|
|
2024
Q1 | $257K | Sell |
3,746
-1,021
| -21% | -$69.9K | ﹤0.01% | 549 |
|
|
2023
Q4 | $276K | Buy |
4,767
+942
| +25% | +$54.5K | ﹤0.01% | 542 |
|
|
2023
Q3 | $202K | Buy |
+3,825
| New | +$202K | ﹤0.01% | 563 |
|
|
2023
Q2 | – | Sell |
-4,033
| Closed | -$202K | – | 563 |
|
|
2023
Q1 | $202K | Sell |
4,033
-3,674
| -48% | -$184K | ﹤0.01% | 506 |
|
|
2022
Q4 | $357K | Buy |
+7,707
| New | +$357K | 0.01% | 423 |
|
|
2022
Q1 | – | Sell |
-6,159
| Closed | -$262K | – | 447 |
|
|
2021
Q4 | $262K | Buy |
6,159
+699
| +13% | +$29.7K | 0.01% | 451 |
|
|
2021
Q3 | $237K | Buy |
+5,460
| New | +$237K | ﹤0.01% | 509 |
|
|
2021
Q2 | – | Sell |
-18,501
| Closed | -$715K | – | 412 |
|
|
2021
Q1 | $715K | Buy |
18,501
+4,016
| +28% | +$155K | 0.02% | 321 |
|
|
2020
Q4 | $521K | Buy |
14,485
+4,436
| +44% | +$160K | 0.02% | 299 |
|
|
2020
Q3 | $384K | Buy |
10,049
+1,774
| +21% | +$67.8K | 0.02% | 203 |
|
|
2020
Q2 | $291K | Sell |
8,275
-5,192
| -39% | -$183K | 0.02% | 209 |
|
|
2020
Q1 | $439K | Buy |
+13,467
| New | +$439K | 0.02% | 313 |
|
|
2019
Q1 | – | Sell |
-1,051
| Closed | -$37K | – | 153 |
|
|
2018
Q4 | $37K | Buy |
+1,051
| New | +$37K | ﹤0.01% | 224 |
|